PMID- 29086534
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20191120
IS  - 2233-6079 (Print)
IS  - 2233-6087 (Electronic)
IS  - 2233-6079 (Linking)
VI  - 41
IP  - 5
DP  - 2017 Oct
TI  - Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position 
      Statement of the Korean Diabetes Association, 2017.
PG  - 367-373
LID - 10.4093/dmj.2017.41.5.367 [doi]
AB  - The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice 
      Guidelines. In 2017, the KDA published a position statement on the use of 
      antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). 
      Growing evidence from new multinational clinical trials using novel and 
      traditional insulin analogues has also been accumulated. Following global trends, 
      many results of clinical trials, especially concerning the clinical efficacy and 
      safety of insulin therapy, have been published about Korean patients with T2DM. 
      After a systematic search of recent evidence, the KDA updated and modified its 
      clinical practice recommendations regarding the initiation, choice, and 
      intensification of insulin and created an insulin treatment algorithm for the 
      first time to guide physicians caring for adult Korean patients with T2DM.
CI  - Copyright (c) 2017 Korean Diabetes Association.
FAU - Lee, Byung Wan
AU  - Lee BW
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei 
      University College of Medicine, Seoul, Korea.
FAU - Kim, Jin Hwa
AU  - Kim JH
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, Chosun 
      University College of Medicine, Gwangju, Korea.
FAU - Ko, Seung Hyun
AU  - Ko SH
AUID- ORCID: 0000-0003-3703-1479
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, 
      College of Medicine, The Catholic University of Korea, Seoul, Korea. 
      kosh@catholic.ac.kr.
FAU - Hur, Kyu Yeon
AU  - Hur KY
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, 
      Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
FAU - Kim, Nan Hee
AU  - Kim NH
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea 
      University College of Medicine, Seoul, Korea.
FAU - Rhee, Sang Youl
AU  - Rhee SY
AD  - Department of Endocrinology and Metabolism, Kyung Hee University School of 
      Medicine, Seoul, Korea.
FAU - Kim, Hyun Jin
AU  - Kim HJ
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, 
      Chungnam National University School of Medicine, Daejeon, Korea.
FAU - Moon, Min Kyong
AU  - Moon MK
AD  - Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical 
      Center, Seoul National University College of Medicine, Seoul, Korea.
FAU - Park, Seok O
AU  - Park SO
AD  - Department of Internal Medicine, Gwangmyeong Sungae Hospital, Gwangmyeong, Korea.
FAU - Choi, Kyung Mook
AU  - Choi KM
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea 
      University College of Medicine, Seoul, Korea.
CN  - Committee of Clinical Practice Guideline of Korean Diabetes Association
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Korea (South)
TA  - Diabetes Metab J
JT  - Diabetes & metabolism journal
JID - 101556588
PMC - PMC5663675
OTO - NOTNLM
OT  - Clinical practice guideline
OT  - Diabetes mellitus, type 2
OT  - Hypoglycemic agents
OT  - Insulin
OT  - Korea
COIS- No potential conflict of interest relevant to this article was reported.
EDAT- 2017/11/01 06:00
MHDA- 2017/11/01 06:01
PMCR- 2017/10/01
CRDT- 2017/11/01 06:00
PHST- 2017/09/08 00:00 [received]
PHST- 2017/09/25 00:00 [accepted]
PHST- 2017/11/01 06:00 [entrez]
PHST- 2017/11/01 06:00 [pubmed]
PHST- 2017/11/01 06:01 [medline]
PHST- 2017/10/01 00:00 [pmc-release]
AID - 41.367 [pii]
AID - 10.4093/dmj.2017.41.5.367 [doi]
PST - ppublish
SO  - Diabetes Metab J. 2017 Oct;41(5):367-373. doi: 10.4093/dmj.2017.41.5.367.